Partners For Kids Communication

This Partners For Kids’ toolkit is designed to help health care professionals regarding nirsevimab, the Respiratory Syncytial Virus (RSV) monoclonal antibody product.  The toolkit includes resources for providers and patients that can be used to support decision-making and patient understanding. The information is updated regularly based on current clinical guidelines, recommendations, and data.

Resources for Health Care Professionals:

• Beyfortus Dosing and Administration Guide (Beyfortus)
• Nirsevimab Frequently Asked Questions (AAP)
• Red Book – AAP Recommendations for the Prevention of RSV Disease in Infants and Children
• Beyfortus (Nirsevimab) Package Insert (Sanofi)

Nirsevimab Implementation Logistics

• Nirsevimab (Beyfortus) Product & Ordering Information (AAP)
• Nirsevimab Readiness Practice Checklist (AAP)
• Nirsevimab and Abrysvo Availability for the 2025-2026 Respiratory Season (Ohio Department of Health)
• Billing Information
  • ODM Memo regarding plan coverage changes
  • CareSource Beyfortus Billing Codes Notice
  • Buckeye Beyfortus Provider Update
    • See February/March 2025 notices regarding Beyfortus

Partners for Kids Resources

• 2024 Webinar Video: Update on Immunization Practices for Prevention of Severe RSV Infection
• 2024 Webinar Slide Deck: Update on Immunization Practices for Prevention of Severe RSV Infection

Maternal RSV Vaccine Resources

• Abrysvo (RSV Vaccine) Discussion Guide
• RSV Vaccine Guidance for Pregnant Women (CDC)

Resources for Patient and Families

• RSV Preventive Antibody Immunization Information Statement  (CDC)
• About RSV (CDC)
• RSV in babies | For Parents (Beyfortus)
• Understanding RSV in babies and infants | For Parents (Beyfortus)